首页 | 本学科首页   官方微博 | 高级检索  
     

中药十八反配伍禁忌的历史沿革与用药分析
引用本文:唐于平,陈 芳,尚尔鑫,段金廒,陶 静,宿树兰,李文林,范欣生. 中药十八反配伍禁忌的历史沿革与用药分析[J]. 世界科学技术-中医药现代化, 2010, 12(4): 593-599
作者姓名:唐于平  陈 芳  尚尔鑫  段金廒  陶 静  宿树兰  李文林  范欣生
作者单位:南京中医药大学江苏省方剂研究重点实验室 南京 210046;贵阳中医学院药学系 贵阳 550002;南京中医药大学江苏省方剂研究重点实验室 南京 210046;南京中医药大学江苏省方剂研究重点实验室 南京 210046;南京中医药大学江苏省方剂研究重点实验室 南京 210046;南京中医药大学江苏省方剂研究重点实验室 南京 210046;南京中医药大学江苏省方剂研究重点实验室 南京 210046;南京中医药大学江苏省方剂研究重点实验室 南京 210046
基金项目:国家重点基础研究发展计划(“973”计划)项目(2011CB505300):基于“十八反”的中药配伍禁忌理论基础研究,负责人:段金廒。
摘    要:古今临床医家把十八反的药物视作配伍禁忌,认为合用后会致毒增毒,然而成功运用反药的例证也代有所传。本文通过对中药十八反的历史演变过程以及在方剂中的应用状况进行分析,发现藜芦组方剂应用在宋元时期达到最高,而甘草和乌头组方剂则是在明清时期最多,3组方剂在民国时期和现代应用均较快下降;并且外用方的比例偏高,方剂药味数有增多的趋势,主要集中在8~9味。本文认为十八反配伍与毒性药材密切相关,是有条件的中药配伍禁忌,如不同的生理病理条件,配比剂量的变化,不同的给药途径,与其它药物配伍使用;其配伍致毒/增毒机理的阐明将为保障中医临床安全合理用药提供科学依据,并有助于推动中药药性理论和中医方剂配伍理论的研究与发展,也将为其他禁忌理论研究提供参考和借鉴。

关 键 词:中药十八反 配伍禁忌 历史沿革 用药分析
收稿时间:2009-12-04
修稿时间:2010-08-17

Evolution and Medicine-using Analysis of Eighteen Incompatible Medicaments in TCM
Tang Yuping,Chen Fang,Shang Erxin,Duan Jinao,Tao Jing,Su Shulan,Li Wenlin and Fan Xinsheng. Evolution and Medicine-using Analysis of Eighteen Incompatible Medicaments in TCM[J]. World Science and Technology—Modernization of Traditional Chinese Medicine and Materia Medica, 2010, 12(4): 593-599
Authors:Tang Yuping  Chen Fang  Shang Erxin  Duan Jinao  Tao Jing  Su Shulan  Li Wenlin  Fan Xinsheng
Affiliation:Jiangsu Key Laboratory for TCM Formulae Research, Nanjing University of Chinese Medicine, Nanjing 210046, China;Department of Pharmacy, Guiyang College of Traditional Chinese Medicine, Guiyang 550002, China
Abstract:Clinical Chinese medical practitioners at all times considered eighteen incompatible medicaments as incompatibility, which would lead to toxicity. However, the tradition to utilize eighteen incompatible medicaments for remedying human disease has been passed down from one generation to another. In this paper, based on the historical development of eighteen incompatible medicaments and analysis of its application in formulae, we found that the formulae in Veratrum group reached the heap in Song and Yuan Dynasties, while, the formulae in Glycyrrhiza and Aconitum group were at most in Ming and Qing Dynasties, but they all gradually disappeared since the 20th century. It is also informed that the formulae containing eighteen incompatible medicaments for external use are more than others, and the number of medicines used in these formulae was higher, usually 8 to 9. Therefore, the eighteen incompatible medicaments which are closely related to toxic medicines is a conditional incompatibility such as different pathophysiologic conditions, variation in ratio and dose, different administration routes and application with other medicines. The clarification of the toxicity mechanism for the eighteen incompatible medicaments would offer scientific support for safe medicine utilization in clinical practice, help to promote the development of TCM property theories and TCM formulae compatibility rules, and provide reference for the research about other incompatibility theory.
Keywords:Eighteen incompatible medicaments   Incompatibility   Evolution   Medicine-using analysis
点击此处可从《世界科学技术-中医药现代化》浏览原始摘要信息
点击此处可从《世界科学技术-中医药现代化》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号